Rating Change
HC Wainwright & Co. reiterated its Buy rating on MoonLake Immunotherapeutics (NASDAQ:MLTX) on August 13, 2026.
reiterateNASDAQ:MLTX
HC Wainwright & Co. Reiterates Buy Rating on MoonLake Immunotherapeutics (MLTX)
HC Wainwright & Co. reiterated its Buy rating on MoonLake Immunotherapeutics (NASDAQ:MLTX) on August 13, 2026.
At publication ·
What changed
MoonLake Immunotherapeutics (NASDAQ:MLTX) · reiterate
- Firm
- HC Wainwright & Co.
- Rating
- Buy to Buy
- Price at event
- $16.64
- Market capitalization
- $895.6M
At a glance
Key takeaways
- HC Wainwright & Co. reiterated a Buy rating on MoonLake Immunotherapeutics (MLTX) on August 13, 2026, with the stock trading at $16.64 and a market capitalization of $895.6 million.
Market Context
MoonLake Immunotherapeutics operates in the Healthcare sector. The stock currently trades at $16.64 with a market capitalization of $895.6M. The stock has declined 67.7% over the past 52 weeks.
Analyst coverage from HC Wainwright & Co. provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for MoonLake Immunotherapeutics.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for MoonLake Immunotherapeutics
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 13, 2026 | HC Wainwright & Co. | Buy | N/A |
| Jul 20, 2026 | HC Wainwright & Co. | Buy | N/A |
| Jul 01, 2026 | Leerink Partners | Outperform | N/A |
| Jun 09, 2026 | BTIG | Buy | N/A |
| Jun 08, 2026 | HC Wainwright & Co. | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View MLTX Stock Page
Frequently Asked Questions
What does the Buy rating mean for MLTX?
A rating of Buy from HC Wainwright & Co. reflects the analyst's outlook on MoonLake Immunotherapeutics (NASDAQ:MLTX). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the MLTX forecast page.